| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hypertension, Vol 8, 506-513, Copyright © 1986 by American Heart Association
I Os, SE Kjeldsen, J Skjoto, A Westheim, K Lande, I Aakesson, P Frederichsen, P Leren, I Hjermann and IK Eide
Baseline plasma vasopressin concentrations were measured in 48 men (all 50
years old) with decreased plasma renin concentration and untreated,
sustained essential hypertension and in 29 healthy normotensive men. Mean
hypertensive plasma vasopressin concentration was more than twice as high
as the corresponding normotensive level (15.7 +/- 2.2 [SE] vs 7.5 +/- 1.0
pg/ml; p less than 0.001). Plasma renin concentration in the hypertensive
group was reduced compared with that in the normotensive group (0.28 +/-
0.04 vs 0.46 +/- 0.06 Goldblatt units X 10(-4)/ml). These differences
appeared despite virtually identical serum osmolality, creatinine
clearance, and urinary sodium excretion in the two groups. In the first 38
hypertensive subjects, arterial plasma epinephrine concentrations were
significantly increased over those of the first 28 control subjects (99 +/-
12 vs 68 +/- 6 pg/ml; p less than 0.025). In contrast to those with low
renin essential hypertension, 35 men with normal renin essential
hypertension (all 40 years old) had normal plasma vasopressin levels that
were not significantly different from those in a comparable normotensive
control group (3.7 +/- 0.8 vs 3.5 +/- 0.4 pg/ml). Arterial epinephrine
concentrations were not significantly different between normal renin
subjects and the control group. After 6 weeks of treatment with the
nonselective beta-adrenergic receptor blocker oxprenolol in 11 subjects
with low renin hypertension, blood pressure was reduced and the plasma
vasopressin concentration fell from 27.6 +/- 6.4 to 13.5 +/- 4.2 pg/ml (p
less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Increased plasma vasopressin in low renin essential hypertension
This article has been cited by other articles:
![]() |
H. E. De Wardener The Hypothalamus and Hypertension Physiol Rev, October 1, 2001; 81(4): 1599 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tahara, Y. Tomura, K.-I. Wada, T. Kusayama, J. Tsukada, M. Takanashi, T. Yatsu, W. Uchida, and A. Tanaka Pharmacological Profile of YM087, A Novel Potent Nonpeptide Vasopressin V1A and V2 Receptor Antagonist, in Vitro and in Vivo J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 301 - 308. [Abstract] [Full Text] |
||||
![]() |
J. Alfie, G. D. Waisman, C. R. Galarza, M. I. Magi, F. Vasvari, L. M. Mayorga, and M. I. Camera Relationship Between Systemic Hemodynamics and Ambulatory Blood Pressure Level Are Sex Dependent Hypertension, December 1, 1995; 26(6): 1195 - 1199. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |